January 14, 2014

UrgentRx, developer of fast-acting over-the-counter flavored powder medications, on Tuesday named Ron Fugate to the company’s board of directors.

January 14, 2014

Three drug makers are looking into buying Pfizer's branded-generics drug business, according to published reports.

January 8, 2014

Generic drug maker Mylan has hired a former Pfizer executive to its executive leadership team.

January 7, 2014

Mylan has launched a generic version of a drug made by Pfizer for treating bladder problems, the company said Tuesday.

January 3, 2014

Teva Pharmaceutical Industries has launched an authorized generic version of a drug used to treat overactive bladder, the company said Friday.

December 26, 2013

Earlier this year, the IMS Institute for Healthcare Informatics, the research wing of the healthcare industry analysis firm IMS Health, dropped a bombshell when it showed that U.S. spending on drugs fell in 2012, the first time that had happened in 55 years.

December 18, 2013

Mylan has acquired rights to an experimental respiratory drug made by Pfizer, Mylan said.

December 17, 2013

Greenstone has launched a version of a drug used to treat fungal infections, the company said.

December 3, 2013

The Food and Drug Administration has given tentative approval to a generic drug for treating community-acquired pneumonia, agency records showed.

December 2, 2013

Pfizer on Monday announced that a wholly-owned Polish subsidiary of Pfizer has acquired the rights to Polocard, a low-dose aspirin (acidum acetylsalicylicum), and the leading over-the-counter brand for heart attack prevention in Poland, from ZF Polpharma SA.

November 25, 2013

Pfizer on Monday launched Robitussin Maximum Strength Cough + Congestion DM, a new liquid-filled capsule that helps control cough on-the-go.

November 22, 2013

The Food and Drug Administration has granted regular approval to a new drug made by Pfizer for treating a form of lung cancer, the drug maker said.

November 6, 2013

A pharmacist in Canada has won a prestigious award from Pfizer Consumer Healthcare, according to published reports.

November 5, 2013

The Food and Drug Administration has approved a generic drug made by Mylan for treating overactive bladder, according to agency records.

October 29, 2013

In what is emerging as the latest battle over follow-on biologics, a new argument has emerged about what to call them, and supporters of biotechnology companies are the latest to take a shot.

October 9, 2013

Pfizer Consumer Healthcare, the makers of ChapStick, on Wednesday announced Alex Morgan, Olympic gold medalist and member of the U.S. Women’s National Soccer Team, as the brand’s newest spokeswoman.

October 8, 2013

The Food and Drug Administration has approved a new treatment for hot flashes and the prevention of osteoporosis, the agency said.

September 30, 2013

Pfizer Consumer Healthcare and the National Hockey League on Monday announced Advil as the Official Partner and the Official Pain Reliever of the NHL and the 30 NHL athletic trainers in North America for the 2013-14 season.

September 30, 2013

Mylan has launched the first generic version of a drug used to treat fungal infections, the company said Monday.

September 25, 2013

The board of directors of the World Self-Medication Industry on Wednesday named as its chair-elect Erica Mann, member of the Bayer HealthCare executive committee and president of Bayer HealthCare’s Global Consumer Care division.

September 13, 2013

ChapStick, part of the Pfizer portfolio of consumer brands, on Friday announced a new lip balm with advanced moisturizing and anti-aging ingredients.

September 10, 2013

One trend that generic companies and pharmacy retailers alike should keep an eye on is the patent cliff.

September 10, 2013

Pfizer Consumer recently launched its Advil Film Coated tablets, and the first-to-market formulation marks the debut of Advil Ion Core Technology in the United States.

September 10, 2013

Generic drugs have been on a roll with their share of total prescriptions dispensed in the country seeming to increase on a nearly constant basis. But it appears the peak is coming soon.